The Brussels stock exchange closed the week and the month on a positive note, driven by gains in UCB and Umicore.
The rally provided a counterweight to a fragmented European market session, where major indices posted mixed results following a week dominated by macroeconomic data releases and corporate earnings reports.
The recovery in Belgian equities follows a period of volatility, with the benchmark having staged a similar rebound earlier in the week.
Investor sentiment appears to be stabilizing around key domestic names, suggesting a rotation into defensive and industrial sectors as traders digest the latest inflation and growth figures.
UCB, the pharmaceutical company, and Umicore, the materials technology group, led the charge.
Their performance helped reverse a string of difficult sessions for the Brussels market, which had been weighed down by broader European uncertainty.